4//SEC Filing
Narayan Prabhu 4
Accession 0001437749-25-004221
CIK 0001742927other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:30 PM ET
Size
6.0 KB
Accession
0001437749-25-004221
Insider Transaction Report
Form 4
Narayan Prabhu
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-13+194,250→ 194,250 totalExercise: $1.80Exp: 2035-02-12→ Common Stock, par value $0.0001 per share (194,250 underlying)
Footnotes (1)
- [F1]The option award was made on February 13, 2025 (the "Grant Date") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The option provides for vesting as follows: (i) 80,938 of the shares subject to the option are immediately vested on the Grant Date, (ii) 89,043 shares subject to the option will vest in equal installments on the last day of each month from March 2025 to December 2026, and (iii) 24,269 shares subject to the option will vest in equal installments on the last day of each month from January 2027 to December 2027. The exercise price is based on the closing price of the Issuer's common stock, par value $0.0001 per share, on the Grant Date in accordance with the terms of the 2020 Plan.
Documents
Issuer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK 0001742927
Entity typeother
Related Parties
1- filerCIK 0001829831
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:30 PM ET
- Size
- 6.0 KB